Vormehr, Mathias; Diken, Mustafa; Boegel, Sebastian et al.
Mutanome directed cancer immunotherapyCURRENT OPINION IN IMMUNOLOGY. Bd. 39. 2016 S. 14-22
Kerstan, A.; Alrefai, H.; Muhammad, K. et al.
NFATc1 promotes imiquimod-induced skin inflammation by negatively controlling IL-10 production in B cellsEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E26-E26
Muhammad, K.; Alrefai, H.; Rudolf, R. et al.
NFATc1 supports imiquimod- induced skin inflammation by suppressing regulatory B cellsEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. 2016 S. 1136-1136
Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cellsNATURE COMMUNICATIONS. Bd. 7. 2016
Alrefai, Hani; Muhammad, Khalid; Rudolf, Ronald et al.
NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells (vol 7, 11724, 2016)Nature Communications. Bd. 7. 2016
Holtappels, Rafaela; Podlech, Juergen; Lemmermann, Niels A. W. et al.
Non-cognate bystander cytolysis by clonal epitope-specific CTL lines through CD28-CD80 interaction inhibits antibody production: A potential caveat to CD8 T-cell immunotherapyCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 44-56
Krebs, F.; Hahn, S.; Mitzel, H. et al.
Novel prognostic marker proteins for malignant melanoma immunotherapyJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 23-23
Backes, Christina; Ludwig, Nicole; Leidinger, Petra et al.
Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascadesONCOTARGET. Bd. 7. H. 44. 2016 S. 71514-71525
Waisman, Ari; Hoevelmeyer, Nadine; Diefenbach, Andreas et al.
Past, present and future of immunology in MainzCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 1-6
Schmidt, Cornelia S.; Lopez, Pamela Aranda; Dopheide, Joern F. et al.
Phenotypic and functional characterization of neutrophils and monocytes from patients with myelodysplastic syndrome by flow cytometryCELLULAR IMMUNOLOGY. Bd. 308. 2016 S. 19-26